NASDAQ: SRZN
Surrozen Inc Earnings Dates, Reports, Calls

Surrozen earnings were -$81.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SRZN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$27.0M, down 3.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SRZN reported annual earnings of -$63.6M, with 47.7% growth.

SRZN earnings history

Current Revenue
$10.7M
Current Earnings
-$81.7M
Current Profit Margin
-766.8%

SRZN Return on Equity

Current Company
N/A
Current Industry
-60.2%
Current Market
31.3%

SRZN undefined

Current Company
-127.5%
Current Industry
-2.5%
SRZN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SRZN announces earnings.

SRZN undefined

Current Company
-78.38%
Current Industry
5.8%
SRZN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SRZN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SRZN-$78.74M-$81.70MN/A-$24.96
VRCA-$55.56M-$65.99MN/A-$1.14
GUTS-$86.61M-$89.11MN/A-$1.86
BMEA-$124.23M-$128.63MN/A-$3.54
IMMX-$20.70M-$20.90MN/A-$0.70

Surrozen Earnings Reports & History FAQ

What were Surrozen's earnings last quarter?

Surrozen (NASDAQ: SRZN) reported Q1 2025 earnings per share (EPS) of -$7.43, up 75.24% year over year. Total SRZN earnings for the quarter were -$26.97 million. In the same quarter last year, Surrozen's earnings per share (EPS) was -$4.24.

If you're new to stock investing, here's how to buy Surrozen stock.

Is Surrozen profitable or losing money?

As of the last Surrozen earnings report, Surrozen is currently losing money. Surrozen's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$81.70 million, a 117.44% increase year over year.

What was SRZN's earnings growth in the past year?

As of Surrozen's earnings date in Q3 2025, Surrozen's earnings has grown year over year. SRZN earnings in the past year totalled -$81.70 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.